http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014265021-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d79362493392629399a529d819cdccd8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-00
filingDate 2014-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b9ae4ea7d5d50ba8d826c2619157b67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78d13db53d1438f6ae0d4ef50a7be569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc63d12117098da4ceab35ce94c98517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fecd35a2a41fd67470690c851787ece
publicationDate 2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2014265021-B2
titleOfInvention Prodrugs of nh-acidic compounds
abstract The invention provides a method of sustained delivery of a lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug by administering to a patient an effective amount of a prodrug compound of the invention wherein upon administration to the patient, release of the parent drug from the prodrug is sustained release. Prodrug compounds suitable for use in the methods of the invention are labile conjugates of parent drugs that are derivatized through carbonyl linked prodrug moieties. The prodrug compounds of the invention can be used to treat any condition for which the lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug is useful as a treatment.
priorityDate 2009-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4837337-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5700946-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5206386-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004026864-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3957808-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3266984-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2418499-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880

Total number of triples: 28.